Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 10912792 Compounds and methods for modulating angiotensinogen expression

Patent 10912792 was granted and assigned to Ionis Pharmaceuticals on February, 2021 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 12 Dec, 2023
"Add patent abstract"
Golden AI profile picture
Golden AI
edited on 12 Dec, 2023
Edits made to:
Article (+435 characters)
Article

Patent abstract

Disclosed herein are compositions and compounds comprising modified oligonucleotides for modulating AGT and modulating a RAAS pathway related disease, disorder and/or condition in an individual in need thereof. A RAAS pathway related disease, disorder and/or condition in an individual such as hypertension can be treated, ameliorated, delayed or prevented with the administration of antisense compounds targeted to AGT.

Edits on 9 Oct, 2023
"Add patent inventor(s)"
Golden AI profile picture
Golden AI
edited on 9 Oct, 2023
Edits made to:
Infobox (+4 properties)
Infobox
Patent Inventor Names
Adam Mullick0
Mark J. Graham0
Punit P. Seth0
Susan M. Freier0
Edits on 30 Jul, 2023
"Resolve patent citation"
Golden AI profile picture
Golden AI
edited on 30 Jul, 2023
Edits on 25 May, 2023
"Remove website redirecting to Patent Public Search front page"
Golden AI profile picture
Golden AI
edited on 25 May, 2023
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=109127920
Edits on 17 May, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 17 May, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11649458 Inhibiting angiotensinogen to attenuate aortic pathology in Marfan syndrome
0
Edits on 25 Apr, 2023
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 25 Apr, 2023
Infobox
Is a
Patent
Patent
0
Patent Applicant
0
Current Assignee
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
109127920
Date of Patent
February 9, 2021
0
Patent Application Number
157639420
Date Filed
October 7, 2016
0
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=109127920
Patent Citations Received
‌
US Patent 11447521 Compounds and methods for modulating angiotensinogen expression
0
Patent Primary Examiner
‌
Tracy Vivlemore
0
Edits on 22 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 22 Apr, 2023
Edits on 21 Sep, 2022
"update inverses"
Golden AI profile picture
Golden AI
edited on 21 Sep, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11447521 Compounds and methods for modulating angiotensinogen expression
0
Edits on 17 Jun, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 17 Jun, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
https://pdfpiw.uspto.gov/.piw?Docid=10912792
Edits on 10 Feb, 2022
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 10 Feb, 2022
Edits made to:
Infobox (+9 properties)
‌

 US Patent 10912792 Compounds and methods for modulating angiotensinogen expression

Infobox
Is a
Patent
Patent
Patent applicant
Current assignee
Patent jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent number
10912792
Date of patent
February 9, 2021
Patent application number
15763942
Date Filed
October 7, 2016
Patent primary examiner
‌
Tracy Vivlemore

Find more entities like US Patent 10912792 Compounds and methods for modulating angiotensinogen expression

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo